New Report: People Living with Diabetes Have False Hope in GLP-1s, Strong Demand for More Engagement and Education
CCS gathered insights from more than 1,500 individuals living with diabetes regarding challenges they face when it comes to managing their chronic disease 57% think... Read more.
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
Dirk Van Hyfte MD, PhD, Co-Founder and Head of Innovation of BioStrand, to present findings live next week at the HIMSS24 conference in Orlando, Florida VICTORIA,... Read more.
Helix Appoints Genentech and Flatiron Health Vet Hylton Kalvaria as SVP of Life Sciences
SAN MATEO, Calif.–(BUSINESS WIRE)–Helix, the leading population genomics company in the nation, today announced that Hylton Kalvaria has joined its leadership... Read more.
Laser Photonics Receives Dual Order From Mine System Solutions for Laser Cleaning and Marking Systems
ORLANDO, Fla.–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and... Read more.
Ciena Reports Fiscal First Quarter 2024 Financial Results
HANOVER, Md.–(BUSINESS WIRE)–Ciena® Corporation (NYSE: CIEN), a networking systems, services and software company, today announced unaudited financial... Read more.
TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101
– Nelitolimod, a class C TLR-9 agonist formerly called SD-101, is the Company’s therapeutic candidate designed to overcome biologic barriers in liver and pancreatic... Read more.
In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups
Largest study of gene expression profile testing in patients with high-risk cutaneous squamous cell carcinoma (SCC) supports test’s ability to provide clinically... Read more.
Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced... Read more.
Upstream Bio Initiates a Phase 2 Clinical Trial of Verekitug (UPB-101) in Severe Asthma and Doses First Patients
Upstream announces the first global Phase 2 asthma study of a biologic inhibiting TSLP signaling including a 24-week dosing regimen and the potential to achieve... Read more.
Restatement of Previously Issued Financial Statements
NEW YORK–(BUSINESS WIRE)–In connection with the preparation of its financial statements for the year ended December 31, 2023, CI&T Inc. (the “Company”),... Read more.